SHARPIN controls the development of regulatory T cells

Immunology

Volumn 148, Issue 2, 2016, Pages 216-226

  Redecke, Vanessa ^a   Chaturvedi, Vandana ^a   Kuriakose, Jeeba ^a   Häcker, Hans ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

LUBAC; Regulatory T cells; SHARPIN; Signal transduction; T cell development

Indexed keywords

CARRIER PROTEINS AND BINDING PROTEINS; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LYMPHOCYTE ANTIGEN RECEPTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; SHANK ASSOCIATED RH DOMAIN INTERACTING PROTEIN; STRESS ACTIVATED PROTEIN KINASE; T LYMPHOCYTE RECEPTOR; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR RECEPTOR; UBIQUITIN; UNCLASSIFIED DRUG; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE; NERVE PROTEIN; SHARPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CATALYSIS; CD25+ T LYMPHOCYTE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL MATURATION; CONTROLLED STUDY; ERYTHROCYTE; FLOW CYTOMETRY; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TH2 CELL; THYMOCYTE; UBIQUITINATION; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; GENETICS; KNOCKOUT MOUSE; LYMPHOCYTE ACTIVATION; METABOLISM; PHYSIOLOGY;

ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; FORKHEAD TRANSCRIPTION FACTORS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NERVE TISSUE PROTEINS; NF-KAPPA B; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY; THYMOCYTES;

EID: 84963649625     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/imm.12604     Document Type: Article

References (50)

1. Zak DE, Schmitz F, Gold ES, Diercks AH, Peschon JJ, Valvo JS et al. Systems analysis identifies an essential role for SHANK-associated RH domain-interacting protein (SHARPIN) in macrophage Toll-like receptor 2 (TLR2) responses. Proc Natl Acad Sci U S A 2011; 108:11536-41.
2. Sasaki K, Iwai K. Roles of linear ubiquitinylation, a crucial regulator of NF-κB and cell death, in the immune system. Immunol Rev 2015; 266:175-89.
3. Dubois SM, Alexia C, Wu Y, Leclair HM, Leveau C, Schol E et al. A catalytic-independent role for the LUBAC in NF-κB activation upon antigen receptor engagement and in lymphoma cells. Blood 2014; 123:2199-203.
4. Wang Z, Potter CS, Sundberg JP, Hogenesch H. SHARPIN is a key regulator of immune and inflammatory responses. J Cell Mol Med 2012; 16:2271-9.
5. HogenEsch H, Torregrosa SE, Boggess D, Sundberg BA, Carroll J, Sundberg JP. Increased expression of type 2 cytokines in chronic proliferative dermatitis (cpdm) mutant mice and resolution of inflammation following treatment with IL-12. Eur J Immunol 2001; 31:734-42.
6. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299:1057-61.
7. + regulatory T cells. Nat Immunol 2003; 4:330-6.
8. Wildin RS, Ramsdell F, Peake J, Faravelli F, Casanova JL, Buist N et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 2001; 27:18-20.
9. Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, Whitesell L et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 2001; 27:20-1.
10. Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell 2008; 133:775-87.
11. van der Veeken J, Arvey A, Rudensky A. Transcriptional control of regulatory T-cell differentiation. Cold Spring Harb Symp Quant Biol 2013; 78:215-22.
12. Bandukwala HS, Rao A. 'Nurr'ishing Treg cells: Nr4a transcription factors control Foxp3 expression. Nat Immunol 2013; 14:201-3.
13. Haiqi H, Yong Z, Yi L. Transcriptional regulation of Foxp3 in regulatory T cells. Immunobiology 2011; 216:678-85.
14. Gupta S, Manicassamy S, Vasu C, Kumar A, Shang W, Sun Z. Differential requirement of PKC-θ in the development and function of natural regulatory T cells. Mol Immunol 2008; 46:213-24.
15. Barnes MJ, Krebs P, Harris N, Eidenschenk C, Gonzalez-Quintial R, Arnold CN et al. Commitment to the regulatory T cell lineage requires CARMA1 in the thymus but not in the periphery. PLoS Biol 2009; 7:e51.
16. Medoff BD, Sandall BP, Landry A, Nagahama K, Mizoguchi A, Luster AD et al. Differential requirement for CARMA1 in agonist-selected T-cell development. Eur J Immunol 2009; 39:78-84.
17. Wan YY, Chi H, Xie M, Schneider MD, Flavell RA. The kinase TAK1 integrates antigen and cytokine receptor signaling for T cell development, survival and function. Nat Immunol 2006; 7:851-8.
18. + regulatory and natural killer-like T cells on signals leading to NF-κB activation. Proc Natl Acad Sci U S A 2004; 101:4566-71.
19. Long M, Park SG, Strickland I, Hayden MS, Ghosh S. Nuclear factor-κB modulates regulatory T cell development by directly regulating expression of Foxp3 transcription factor. Immunity 2009; 31:921-31.
20. + regulatory T cells is driven by the c-Rel enhanceosome. Immunity 2009; 31:932-40.
21. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006; 441:235-8.
22. Rudensky AY. Regulatory T cells and Foxp3. Immunol Rev 2011; 241:260-8.
23. Sekiya T, Kashiwagi I, Yoshida R, Fukaya T, Morita R, Kimura A et al. Nr4a receptors are essential for thymic regulatory T cell development and immune homeostasis. Nat Immunol 2013; 14:230-7.
24. + regulatory T cells. Autoimmunity 2006; 39:445-53.
25. + T regulatory cells. Nat Immunol 2003; 4:337-42.
26. Hacker H, Chi L, Rehg JE, Redecke V. NIK prevents the development of hypereosinophilic syndrome-like disease in mice independent of IKKα activation. J Immunol 2012; 188:4602-10.
27. Sharma R, Sung SS, Fu SM, Ju ST. Regulation of multi-organ inflammation in the regulatory T cell-deficient scurfy mice. J Biomed Sci 2009; 16:20.
28. - T cells are the effector cells in disease pathogenesis in the scurfy (sf) mouse. J Immunol 1994; 153:3764-74.
29. Noval Rivas M, Burton OT, Wise P, Charbonnier LM, Georgiev P, Oettgen HC et al. Regulatory T cell reprogramming toward a Th2-cell-like lineage impairs oral tolerance and promotes food allergy. Immunity 2015; 42:512-23.
30. Yu F, Sharma S, Edwards J, Feigenbaum L, Zhu J. Dynamic expression of transcription factors T-bet and GATA-3 by regulatory T cells maintains immunotolerance. Nat Immunol 2015; 16:197-206.
31. + regulatory T cells. Nat Rev Immunol 2011; 11:119-30.
32. + regulatory T cells induces a scurfy-like disease. J Exp Med 2007; 204:57-63.
33. + cells control Th2 responses in a murine model of atopic dermatitis. J Invest Dermatol 2012; 132:1672-80.
34. + regulatory T cells. Proc Natl Acad Sci U S A 2007; 104:18169-74.
35. Wan YY, Flavell RA. Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature 2007; 445:766-70.
36. H 2 responses. Nature 2009; 458:351-6.
37. Moran AE, Holzapfel KL, Xing Y, Cunningham NR, Maltzman JS, Punt J et al. T cell receptor signal strength in Treg and iNKT cell development demonstrated by a novel fluorescent reporter mouse. J Exp Med 2011; 208:1279-89.
38. + CD4 regulatory T cells. J Exp Med 2009; 206:3001-14.
39. Ruland J, Duncan GS, Elia A, del Barco Barrantes I, Nguyen L, Plyte S et al. Bcl10 is a positive regulator of antigen receptor-induced activation of NF-κB and neural tube closure. Cell 2001; 104:33-42.
40. Hara H, Wada T, Bakal C, Kozieradzki I, Suzuki S, Suzuki N et al. The MAGUK family protein CARD11 is essential for lymphocyte activation. Immunity 2003; 18:763-75.
41. Ruefli-Brasse AA, French DM, Dixit VM. Regulation of NF-κB-dependent lymphocyte activation and development by paracaspase. Science 2003; 302:1581-4.
42. Vahl JC, Drees C, Heger K, Heink S, Fischer JC, Nedjic J et al. Continuous T cell receptor signals maintain a functional regulatory T cell pool. Immunity 2014; 41:722-36.
43. Lee HM, Bautista JL, Scott-Browne J, Mohan JF, Hsieh CS. A broad range of self-reactivity drives thymic regulatory T cell selection to limit responses to self. Immunity 2012; 37:475-86.
44. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 1998; 188:287-96.
45. + naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int Immunol 1998; 10:1969-80.
46. Szymczak-Workman AL, Workman CJ, Vignali DA. Cutting edge: regulatory T cells do not require stimulation through their TCR to suppress. J Immunol 2009; 182:5188-92.
47. Yang Y, Schmitz R, Mitala J, Whiting A, Xiao W, Ceribelli M et al. Essential role of the linear ubiquitin chain assembly complex in lymphoma revealed by rare germline polymorphisms. Cancer Discov 2014; 4:480-93.
48. Sasaki Y, Sano S, Nakahara M, Murata S, Kometani K, Aiba Y et al. Defective immune responses in mice lacking LUBAC-mediated linear ubiquitination in B cells. EMBO J 2013; 32:2463-76.
49. Rantala JK, Pouwels J, Pellinen T, Veltel S, Laasola P, Mattila E et al. SHARPIN is an endogenous inhibitor of β1-integrin activation. Nat Cell Biol 2011; 13:1315-24.
50. Pouwels J, Nevo J, Pellinen T, Ylanne J, Ivaska J. Negative regulators of integrin activity. J Cell Sci 2012; 125:3271-80.